跳至主要内容
临床试验/NCT05021627
NCT05021627尚未招募不适用

A Multicenter Randomized Controlled Study of Cardiac Autonomic Nerve Improvement and Pacemaker Therapy in Patients With Sinus Bradycardia

Shanghai Chest Hospital0 个研究点目标入组 240 人开始时间: 2021年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
240
主要终点
Symptom score after operation

研究概览

简要总结

This is a multicenter randomized controlled study. By comparing patients with sinus bradycardia undergoing cardiac autonomic ganglion ablation and pacemaker therapy, and long-term follow-up to evaluate its safety and effectiveness after surgery, in order to evaluate the safety and effectiveness of cardiac autonomic ganglion ablation in the treatment of sinus bradycardia.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Aged 18 to 80 years old;
  • Symptomatic sinus bradycardia;
  • Not meet the class I indications for pacemaker implantation.

排除标准

  • Structural heart disease, heart surgery history;
  • Drug-induced SB, sinus pause >2.0 s, positive atropine test, corrected sinus node recovery time (cSNRT) >525 ms;
  • Any atrial or ventricular arrhythmia, or a history of ablation procedures to treat atrial tachyarrhythmias;
  • With Significant congenital heart disease, ejection fraction was <40% measured by echocardiography;
  • Allergic to contrast media;
  • Contraindication to anticoagulation medications;
  • Severe pulmonary disease e.g. restrictive pulmonary disease, chronic obstructive disease (COPD);
  • Poor general health; 10.Life expectancy less than 6 months.

结局指标

主要结局

Symptom score after operation

时间窗: 48 months

Each patient subjectively assessed his or her SB-related symptom, including dizziness, fatigue, and palpitation, on a score of 1 to 10 points (mildtosevere). The total SB-related symptom score for each patient was calculated as the sum of all scores for individual symptoms.

次要结局

  • Quality of life score(48 months)
  • Psychological quality score(48 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Xu Liu

Professor

Shanghai Chest Hospital

相似试验